China Resources Pharmaceutical Group Limited (HKG:3320)

HKG:3320 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16,425	24,651	15,224	17,513	11,231
Short-Term Investments	-	7,581	7,507	11,988	6,914
Cash & Short-Term Investments	16,425	32,231	22,731	29,501	18,146
Cash Growth	-49.04%	41.79%	-22.95%	62.58%	-0.14%
Accounts Receivable	83,168	95,695	84,818	95,958	86,787
Other Receivables	8,177	6,912	6,845	9,344	7,359
Receivables	91,345	102,607	91,663	105,302	94,146
Inventory	37,053	31,875	26,547	29,688	24,585
Prepaid Expenses	4,070	4,797	4,953	4,304	3,740
Restricted Cash	-	-	-	12.75	-
Other Current Assets	36,954	7,057	6,366	7,802	6,492
Total Current Assets	185,846	178,568	152,259	176,610	147,109
Property, Plant & Equipment	25,907	25,043	21,698	25,038	22,642
Long-Term Investments	6,143	6,878	6,622	7,841	6,334
Goodwill	22,369	21,454	20,409	24,902	21,072
Other Intangible Assets	8,508	6,536	6,359	7,548	5,762
Long-Term Deferred Tax Assets	1,969	1,773	1,435	1,310	969.85
Long-Term Deferred Charges	-	1,481	1,206	1,453	1,178
Other Long-Term Assets	7,018	5,037	5,546	3,862	3,437
Total Assets	257,760	246,770	215,534	248,562	209,372
Accounts Payable	58,598	54,451	48,853	52,380	45,697
Accrued Expenses	4,734	4,231	5,360	5,187	4,049
Short-Term Debt	-	-	10,167	12,297	11,196
Current Portion of Long-Term Debt	44,853	45,760	35,941	46,962	40,127
Current Portion of Leases	520.27	463.53	495.95	583.81	709.96
Current Income Taxes Payable	954.9	730.03	667.3	894.39	671.13
Current Unearned Revenue	4,225	4,023	3,538	3,557	2,478
Other Current Liabilities	18,337	24,574	16,747	19,461	17,691
Total Current Liabilities	132,222	134,233	121,770	141,323	122,620
Long-Term Debt	22,864	15,092	9,042	7,181	2,008
Long-Term Leases	768.14	844.89	770.27	931.86	1,156
Long-Term Unearned Revenue	-	788.58	775.14	890.78	651.44
Long-Term Deferred Tax Liabilities	1,915	1,718	1,587	1,965	1,669
Other Long-Term Liabilities	1,130	356.96	203.29	197.83	206.37
Total Liabilities	159,673	153,795	134,977	153,578	129,342
Common Stock	24,630	24,630	24,630	27,241	27,241
Retained Earnings	-	29,705	26,731	28,397	25,382
Comprehensive Income & Other	23,614	-8,376	-7,804	-4,657	-6,153
Total Common Equity	48,244	45,960	43,557	50,981	46,470
Minority Interest	49,843	47,015	37,000	44,003	33,560
Shareholders' Equity	98,087	92,975	80,557	94,984	80,029
Total Liabilities & Equity	257,760	246,770	215,534	248,562	209,372
Total Debt	69,005	62,161	56,416	67,956	55,197
Net Cash (Debt)	-52,580	-29,930	-33,685	-38,455	-37,051
Net Cash Per Share	-8.37	-4.76	-5.36	-6.12	-5.90
Filing Date Shares Outstanding	6,283	6,283	6,283	6,283	6,283
Total Common Shares Outstanding	6,283	6,283	6,283	6,283	6,283
Working Capital	53,624	44,335	30,489	35,287	24,489
Book Value Per Share	7.68	7.32	6.93	8.11	7.40
Tangible Book Value	17,367	17,969	16,789	18,532	19,636
Tangible Book Value Per Share	2.76	2.86	2.67	2.95	3.13
Buildings	-	16,124	13,507	15,946	14,334
Machinery	-	12,511	10,556	11,496	9,920
Construction In Progress	-	1,339	1,930	1,193	633.67
Leasehold Improvements	-	960.31	741.77	810.38	697.55

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.